BIIB Competitors & Rivals
Compare Biogen Inc with top Pharmaceuticals companies
Biogen Inc
BIIB - Health Care
Market Cap
$28.2B
Price
$191.82
P/E Ratio
21.82
Revenue Growth
-0.1%
Top Competitors
Side-by-Side Comparison
| Metric | BIIB | AAPL | MSFT | GOOGL |
|---|---|---|---|---|
| Price | $191.82 | $264.55 | $397.23 | $315.20 |
| Market Cap | $28.2B | N/A | N/A | N/A |
| P/E Ratio | 21.82 | 33.85 | 36.30 | 28.58 |
| Revenue Growth | -0.1% | 6.4% | 14.9% | 15.1% |
| Profit Margin | 0.1% | 0.3% | 0.4% | 0.3% |
Detailed Head-to-Head Comparisons
Get in-depth analysis comparing BIIB with each competitor
Frequently Asked Questions
Who are BIIB's main competitors?
BIIB's main competitors include AAPL, MSFT, GOOGL, and other companies in the Pharmaceuticals industry. These companies compete directly with Biogen Inc for market share and customers.
How does BIIB compare to its competitors?
BIIB can be compared to competitors using metrics like market capitalization, P/E ratio, revenue growth, profit margins, and market share. Each competitor has different strengths - some may have better valuations while others have higher growth rates.
What are the best alternatives to BIIB stock?
The best alternatives to BIIB depend on your investment goals. For similar market exposure, consider AAPL or MSFT. For different risk profiles, research companies with varying market caps and growth trajectories in the Pharmaceuticals sector.
Which is better: BIIB or AAPL?
Comparing BIIB vs AAPL requires analyzing valuation metrics, growth prospects, competitive advantages, and risk factors. Neither is universally "better" - the right choice depends on your investment strategy, risk tolerance, and market outlook.
What makes BIIB different from its competitors?
Biogen Inc differentiates itself through its unique business model, product offerings, market positioning, and competitive advantages. Factors like brand strength, innovation, operational efficiency, and financial health distinguish BIIB from rivals.
Should I diversify across BIIB and its competitors?
Diversifying across multiple companies in the same industry can reduce company-specific risk while maintaining sector exposure. However, this doesn't eliminate sector risk. Consider diversifying across different industries and sectors for better risk-adjusted returns.
Continue Your Research
Explore more analysis tools for BIIB